Fifth Third Bancorp’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Fifth Third Bancorp’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,500	Closed	-$19K	–	2298
2016 Q4	$19K	Hold	1,500	–	–	﹤0.01%	1630
2016 Q3	$21K	Hold	1,500	–	–	﹤0.01%	1614
2016 Q2	$11K	Hold	1,500	–	–	﹤0.01%	1786
2016 Q1	$10K	Hold	1,500	–	–	﹤0.01%	1873
2015 Q4	$9K	Hold	1,500	–	–	﹤0.01%	2010
2015 Q3	$9K	Hold	1,500	–	–	﹤0.01%	2093
2015 Q2	$12K	Hold	1,500	–	–	﹤0.01%	2030
2015 Q1	$12K	Hold	1,500	–	–	﹤0.01%	1958
2014 Q4	$10K	Hold	1,500	–	–	﹤0.01%	1952
2014 Q3	$8K	Hold	1,500	–	–	﹤0.01%	2073
2014 Q2	$10K	Hold	1,500	–	–	﹤0.01%	2032
2014 Q1	$12K	Buy	+1,500	New	+$11.7K	﹤0.01%	1953
2013 Q4	–	Sell	-1,340	Closed	-$25K	–	2292
2013 Q3	$25K	Buy	+1,340	New	+$26K	﹤0.01%	1592

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Fifth Third Bancorp's ARIA Position: Q1 2017 in Review

Fifth Third Bancorp sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 1,500 shares — an estimated $19K sold.

Fifth Third Bancorp first reported a position in ARIA in Q3 2013 and held it in 13 quarters. The position peaked at $25K in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Fifth Third Bancorp reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Fifth Third Bancorp sold 1,500 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $19K.
Fifth Third Bancorp first reported a position in Ariad Pharmaceuticals Inc in Q3 2013 and held it in 13 quarters.
Fifth Third Bancorp's Ariad Pharmaceuticals Inc position peaked at $25K in Q3 2013.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Fifth Third Bancorp's 13F filing for Q1 2017, filed 12 May 2017.